---
title: "VNRX.US (VNRX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VNRX.US/news.md"
symbol: "VNRX.US"
name: "VNRX.US"
parent: "https://longbridge.com/en/quote/VNRX.US.md"
datetime: "2026-05-22T00:45:58.424Z"
locales:
  - [en](https://longbridge.com/en/quote/VNRX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VNRX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VNRX.US/news.md)
---

# VNRX.US (VNRX.US) — Related News

### [Full Transcript: VolitionRX Q1 2026 Earnings Call](https://longbridge.com/en/news/286578207.md)
*2026-05-15T13:46:42.000Z*
> VolitionRX (AMEX:VNRX) reported Q1 2026 earnings with revenue of approximately $1 million, up from $0.2 million in Q1 20

### [Volitionrx | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 1 M](https://longbridge.com/en/news/286463768.md)
*2026-05-14T20:30:27.000Z*
### [VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update | VNRX Stock News](https://longbridge.com/en/news/286460343.md)
*2026-05-14T12:10:26.000Z*
> VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update | VNRX Stock News

### [VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update | VNRX Stock News](https://longbridge.com/en/news/285940675.md)
*2026-05-11T04:20:30.000Z*
> VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update | VNRX Stock News

### [08:17 ETVolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats](https://longbridge.com/en/news/285375979.md)
*2026-05-06T12:18:58.000Z*
> VolitionRx Limited has submitted a clinical manuscript for peer review regarding its Nu.Q® Vet Feline prototype assay, w